Inozyme Pharma

Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical development

Model

01Company Overview

Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Their lead product candidate is INZ-701, an enzyme replacement therapy in clinical development for calcification disorders linked to mutations in the ENPP1 and ABCC6 genes.

02Backed By1 investor

SVSanofi Ventures→

03Recent Activity

Is this your company? Claim your profile

FROM RA Capital Management

Portfolio company Inozyme was acquired by BioMarin in May 2025.